Heparin-coated Cardiopulmonary Bypass Circuits Reduce Circulating Complement Factors and Interleukin-6 in Paediatric Heart Surgery

References

• Steinberg JB, Kapelanski DP, Olson JD, Weiler JM. Cytokine and complement levels in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 1993; 106: 1008–16.
   PubMed Web of Science ®Google Scholar
• Borowiec JVV, Hagman L, Tötterman TH, Pekna M, Venge P. Thelin S. Circulating cytokines and granulo-cyte-derived enzymes during complex heart surgery. Scand J Thorac Cardiovasc Surg 1995; 29: 167–74.
   Google Scholar
• Kirklin JK, Westaby S, Blackstone EH, Kirklin JVV, Chenoweth DE, Pacifico AD. Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg 1983; 86: 845–57.
   PubMed Web of Science ®Google Scholar
• Emofsson M, Thelin S, Siegbahn A. Monocyte tissue factor expression, cell activation, and thrombin forma-tion during cardiopulmonary bypass: a clinical study. J Thorac Cardiovasc Surg 1997; 113: 576–84.
   Google Scholar
• Seghaye MC, Duchateau J, Grabitz RG, et al. Comple-ment activation during cardiopulmonary bypass in infants and children. Relation to postoperative multiple system organ failure. J Thorac Cardiovasc Surg 1993; 106: 978–87.
   PubMed Web of Science ®Google Scholar
• Butler J, Pathi VL, Paton RD, et al. Acute-phase response to cardiopulmonary bypass in children weigh-ing less than 10 kilograms. Ann Thorac Surg 1996; 62: 538–42.
   PubMed Web of Science ®Google Scholar
• Finn A, Naik S, Klein N, Levinsky RJ, Strobel S, Elliott M. Interleukin-8 release and neutrophil degranulation after pediatric cardiopulmonary bypass. J Thorac Cardiovasc Surg 1993; 105: 234–41.
   PubMed Web of Science ®Google Scholar
• Saatvedt K, Lindberg OR, Geiran S, et al. Complement activation and release of tumour necrosis factor alpha, interleukin-2, interleukin-6 and soluble tumour necrosis factor and interleukin-2 receptors after cardiopulmonary bypass in children. Scand J Clin Lab Invest 1995; 55: 359–67.
   PubMed Web of Science ®Google Scholar
• Bagge L, Thelin S, Hultman J, Nilsson L, Thorelius J, Hillström PA. Heparin-coated CPB-sets increase bio-compatibility and reduce endothelial cell damage in pigs. J Cardiothorac Anesth 1989; 3 (Suppl 5): 84.
   Google Scholar
• Videm V. Mollnes TE, Garred P. Svennevig JL. Biocompatibility of extracorporeal circulation: in vitro comparison of heparin coated and uncoated oxygenator circuits. J Thorac Cardiovasc Surg 1991; 101: 654–60.
   Google Scholar
• Steinberg BM, Grossi EA, Schwartz DS, et al. Heparin bonding of bypass circuits reduces cytokine release during cardiopulmonary bypass. Ann Thorac Surg 1995; 60: 5252–9.
   Google Scholar
• Fosse E, Moen O, Johnson E, et al. Reduced comple-ment and granulocyte activation with heparin-coated cardiopulmonary bypass. Ann Thorac Surg 1994; 58: 472–7.
   PubMed Web of Science ®Google Scholar
• Svenmarker S, Sandstrom E, Karlsson T, et al. Clinical effects of the heparin coated surface in cardiopulmonary bypass. Eur J Cardiothorac Surg 1997; 11: 957–64.
   PubMed Web of Science ®Google Scholar
• Redmond JM, Gillinov AV, Stuart RS, et al. Heparin-coated bypass reduce pulmonary injury. Ann Thorac Surg 1993; 56: 474–8.
   PubMed Web of Science ®Google Scholar
• Ashraf S, Tian Y, Cowan D, Entress A, Martin PG, Watterson KG. Release of proinflammatory cytokines during pediatric cardiopulmonary bypass: heparin-bonded versus nonbonded oxygenators. Ann Thorac Surg 1997; 64: 1790–4.
   PubMed Web of Science ®Google Scholar
• Schreurs IIH, Wijers MJ, Gu J, et al. Heparin-coated bypass circuits: effects on inflammatory response in pediatric cardiac operations. Ann Thorac Surg 1998; 66: 166–71.
   PubMed Web of Science ®Google Scholar
• Nilsson-Ekdahl K, Nilsson B, Pekna M, Nilsson UR. Generation of iC3 on the interphase between blood and gas. Scand J Immunol 1992; 35: 85–91.
   PubMed Web of Science ®Google Scholar
• Mollnes TE, Lea T, Ft-Oland SS, Harboe M. Quantifica-tion of the terminal complement complex in human plasma by an enzyme-linked immunosorbent assay based on monoclonal antibodies against neoantigen on the complex. Scand J Immunol 1985; 22: 703–10.
   Google Scholar
• Olofsson T, Olsson I, Venge P. Myeloperoxidase and lactoferrin of blood neutrophils and plasma in chronic granulocytic leukemia. Scand J Haematol 1977; 18: 113–20.
   Google Scholar
• Chenoweth DE, Cooper SW, Hugh TE, Stewart RW, Blackstone EH, Kirklin JVV. Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins. N Engl J Med 1981; 304: 497–503.
   PubMed Web of Science ®Google Scholar
• Mollnes TE, Videm V, Riesenfeld J, et al. Complement activation and bioincompatibility. The terminal comple-ment complex for evaluation, and surface modification with heparin for improvement of biomaterials. Clin Exp Immunol 1991; 88 (Suppl 1): 21–6.
   Google Scholar
• Bjork J, Hugh TE, Smedsgaard G. Microvasculature effect of anaphylatoxins C3a and C5a. J Immunol 1985; 134: 1115–9.
   Google Scholar
• Balkwill FR, Burke F. The cytokine network. Immunol Today 1989; 10: 299–304.
   PubMedGoogle Scholar
• de Waal Malefyt RW, Abrams J, Bennett B, Figdor CG, de Vries JE. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991; 174: 1209–20.
   PubMed Web of Science ®Google Scholar
• Venge P. The monitoring of inflammation by specific cellular markers. Scand J Clin Lab Invest 1994; 54 (Suppl 219): 47–54.
   Google Scholar
• Aronen M, Leijala M, Men i S. Value of C-reactive protein in reflecting the magnitude of complement activation in children undergoing open heart surgery. Int Care Med 1990; 16: 128–32.
   Google Scholar
• Boiselair MD, Lane DA, Philippou H, et al. Mechanisms of thrombin generation during surgery and cardiopul-monary bypass. Blood 1993; 82: 3350–7.
   PubMed Web of Science ®Google Scholar
• Scholz W, McClurg MR, Cardenas GJ, et al. C5a-mediated release of interleukin 6 by human monocytes. Clin Immunol Immunopathol 1990; 57: 297–307.
   PubMedGoogle Scholar
• Butler J, Parker D, Pillai R, Westaby S, Shale DJ, Rocker GM. Effect of cardiopulmonary bypass on systemic release of neutrophil elastase and tumor necrosis factor. J Thorac Cardiovasc Surg 1993; 105: 25–30.
   PubMed Web of Science ®Google Scholar
• Andrew M, Mitchell L, Vegh P. Ofosu F. Thrombin regulation in children differs from adults in the absence and presence of heparin. Thromb Haemost 1994; 72: 836–42.
   Google Scholar
• Emofsson M, Thelin S, Siegbahn A. Thrombin genera-tion during cardiopulmonary bypass using heparin-coated or standard circuits. Scand J Thorac Cardiovasc Surg 1995; 29: 157–65.
   Google Scholar
• Chan AKC, Leaker M, Burrows FA, et al. Coagulation and fibrinolytic profile of pediatric patients undergoing cardiopulmonary bypass. Thromb Haemost 1997; 77: 270–7 (Erratum appears in Thromb Haemost 1997; 77: 1047).
   PubMed Web of Science ®Google Scholar